Please login to the form below

Not currently logged in
Email:
Password:

Evista

This page shows the latest Evista news and features for those working in and with pharma, biotech and healthcare.

Lilly’s president and chief executive John Lechleiter to retire

Lilly’s president and chief executive John Lechleiter to retire

Sales of blockbuster lung cancer treatment Alimta (pemetrexed disodium) have suffered with UK and German courts ruling in favour of the generic competition, while patents for Lilly's osteoporosis drug Evista

Latest news

More from news
Approximately 2 fully matching, plus 23 partially matching documents found.

Latest from PMHub

  • Maximising ROI from mature brands

    News that Eli Lilly and Co has forecast a drop in 2014 profits and reduced its sales outlook because of generic competition to its Cymbalta antidepressant and Evista drug for osteoporosis,

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...

Infographics